Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T18:27:30.378Z.
Calculation as of: 2026-10-06T18:27:30.378Z.
Quote observation: 2026-10-06T18:25:09.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fb4a8502ebbb15e11e68a15a33f7d53c7b5c9812bb79594c7d74d11368e8432a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Milestone Pharmaceuticals Inc.
Market Cap
$97.32M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$92.85M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$92.47M
Operating Cash Flow Yield
10516.46%
TTM Avg
3068.81%
3Y Avg
3068.81%
5Y Avg
3068.81%
Market Cap
$102.69M
Operating Cash Flow Yield
5.25%
TTM Avg
2.90%
3Y Avg
5.27%
5Y Avg
4.78%
Market Cap
$103.06M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$103.43M
Operating Cash Flow Yield
N/A
TTM Avg
12.54%
3Y Avg
12.54%
5Y Avg
12.54%
Market Cap
$91.46M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $97.32M | N/A | N/A | N/A | N/A |
| Korro Bio, Inc. (KRRO)vs › | $96.85M | N/A | N/A | N/A | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $92.85M | N/A | N/A | N/A | N/A |
| PolyPid Ltd. (PYPD)vs › | $99.23M | N/A | N/A | N/A | N/A |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $92.47M | 10516.46% | 3068.81% | 3068.81% | 3068.81% |
| The Joint Corp. (JYNT)vs › | $102.69M | 5.25% | 2.90% | 5.27% | 4.78% |
| OnKure Therapeutics, Inc. (OKUR)vs › | $103.06M | N/A | N/A | N/A | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $103.43M | N/A | 12.54% | 12.54% | 12.54% |
| Biomea Fusion, Inc. (BMEA)vs › | $91.46M | N/A | N/A | N/A | N/A |
| Equillium, Inc. (EQ)vs › | $91.36M | N/A | 23.25% | 23.25% | 23.25% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
